New York City, NY -- (SBWIRE) -- 08/19/2013 -- StockMarketIntel.com issues a special report on the following stocks: Affymax, Inc. (OTCMKTS:AFFY), BluForest Inc (OTCMKTS:BLUF), Advanced Cell Technology, Inc. (OTCBB:ACTC), Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY)
Affymax, Inc. (OTCMKTS:AFFY) trading on 350,118 shares, to end the trade at $1.58. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.78and was moved to the maximum level of $27.74. The stock changed hands in a range of $1.51 to $1.59, bringing its market capitalization to about $59.23 million. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Can Investors Bet on AFFY after this News update? Find out in this Research Report
BluForest Inc (OTCMKTS:BLUF) added 11.03%, to complete the trading session at $1.51, with a total volume of 355,450 shares. The stock, on average, trades on a volume of 234,858 shares. In the past 52 weeks, the share price has not declined below $0.11 and above $157.50. It floated in a range of $1.39 to $1.57 during the last trading session, with a beta value of -702.90. Its market capitalization now moved to about $156.25 million. Bluforest Inc., a development stage company, focuses on operating as a carbon offsets marketing company. It intends to market and sell Verified Emission Reduction and Reduced Emissions from Deforestation and Degradation carbon offsets through global restoration projects.
What was the Moving Force behind BLUF on Bullish Run? Read This Research Report
Advanced Cell Technology, Inc. (OTCBB:ACTC) recorded a fall of -1.14% and was in a range of $0.07-$0.07 before closing at $0.0692. The share price hit its 52-week low of $0.05 and $0.10 was the best price. The stock completed the day with a total volume of 6.47 million shares, versus an average volume of 7.67 million shares. Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintained a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.
Will ACTC Get Buyers Even After The Recent Rally? Find Out Here
Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY) added 0.66%, bringing its market capitalization around $3.38 million. The total number of shares that changed hands during the session was 46,736 shares, as compared to average trading volume of 90,869 shares. The share price, after opening at $9.03, made a high of $9.13 and hovered above $9.03 to end the day at $9.11. Telecom Corporation of New Zealand Limited, together with its subsidiaries, provides telecommunications services, information technology (IT) services, and network services in New Zealand and Australia.
Why Should Investors Buy NZTCY After The Recent Gain? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)